Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope? - Wikidata - awgldk - TriplyDB

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

http://www.wikidata.org/entity/Q33654306

about

Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients.Cardiovascular Disease and Diabetes: Two Sides of the Same Coin!

P2860

Q36844897-B6613C7C-A560-4787-B4A7-4013016782C0 Q57931390-49DBBB56-3FE4-45B2-9A73-38C560EBE158

P2860

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

http://www.wikidata.org/entity/Q33654306

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@ast

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@en

type

label

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@ast

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@en

prefLabel

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@ast

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@en

P1433

Q33654306-FE41F42E-209F-4584-90F7-7262E250263B

P1476

Q33654306-000D6A73-99C1-4C85-90EB-051304D53D2B

P2093

Q33654306-5F2BFDC3-A98E-408C-BB0E-21E763CB805D

Q33654306-891F2441-4EEA-4300-A0DE-CDE16A2E8298

Q33654306-DC6CB73C-6C77-46A0-914A-E4FBF35760AE

P2860

Q33654306-0224C733-D34F-46F1-8B8D-A2FAAC77D1AF

Q33654306-1CAF0617-C75F-4C02-975C-C25FEF0EFB1C

Q33654306-1D05206C-E853-41D4-9FD7-0EBE280DFE61

Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4

Q33654306-2152FDC8-F90E-4B4E-B219-A89440C65192

Q33654306-297FCF82-F6FC-439B-BFF7-B5B5AD10353D

Q33654306-2CD6E6AD-8B03-4133-99D0-4F4B6B2B3F90

Q33654306-3288D6E4-87BD-4F4E-B5A5-345B3B1CC831

Q33654306-3B27EB5F-70F7-43AC-BBD5-492AAF8F8F9B

Q33654306-3C418C89-2714-4BF7-9E19-D2D5F63C64A4

P2888

Q33654306-DF3E5A4F-5512-4B3C-9DF0-1BC9AFD62C47

P304

Q33654306-A01667B3-8C9B-4824-8FB6-7373459B1C5B

P31

Q33654306-BA387466-FFBC-487E-A671-57D03584A0F7

P356

Q33654306-1E0ED0B1-9268-45A6-96C8-031F35CF00B6

P433

Q33654306-74C1F70E-FDBF-473F-868F-4110423E39F3

P478

Q33654306-4868FB81-BD7D-4A83-96D4-1BD5B7CFC144

P577

Q33654306-CAA20131-2F1D-4C63-B60A-6A73F0CC6B72

P6179

Q33654306-D77AA9A0-9D09-47DC-9637-03C6E6EBBA19

P698

Q33654306-35147BA2-4A50-4EC7-900B-162787F3BDEC

P932

Q33654306-C2CC1CAE-CB08-4BCF-8DC7-DB8478F80E63

P356

0973-3930.54287

P1433

International Journal of Diabetes in Developing Countries

P1476

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

@en

P2093

Abdul Rashid A Rahman

http://www.w3.org/2001/XMLSchema#string

Aziz Al-Shafi Ismail

http://www.w3.org/2001/XMLSchema#string

Sayeeda Rahman

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes.

Rosiglitazone monotherapy is effective in patients with type 2 diabetes.

Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore

P2888

0973-3930.54287

P304

110-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0973-3930.54287

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1072241870

http://www.w3.org/2001/XMLSchema#string

P698

20165647

http://www.w3.org/2001/XMLSchema#string

P932

2822214

http://www.w3.org/2001/XMLSchema#string